Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma
This study has been terminated.
(The study has been halted due to the low enrolment rate.)
Sponsor:
BioAlliance Pharma SA
Information provided by (Responsible Party):
BioAlliance Pharma SA
ClinicalTrials.gov Identifier:
NCT01045915
First received: January 8, 2010
Last updated: January 7, 2013
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | January 2013 |
| Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |